MDM4 and cancer: Based on these results, we propose that both MDM4 and MDM2 are efficient therapeutic targets in wt TP53 tumors cells with high MDM4 expression, whereas MDM2, but not necessarily MDM4, presents a possible therapeutic target in wt TP53 cancer cells with low MDM4 expression.